VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30027795 | HIV | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
TVIS30027796 | HIV | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
TVIS30027797 | HIV | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
TVIS20017420 | HPV | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
TVIS44046395 | HTLV-1 | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
TVIS44046394 | HTLV-1 | ENSG00000166224.19 | protein_coding | SGPL1 | No | No | 8879 | O95470 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | SGPL1 |
---|---|
DrugBank ID | DB00114 |
Drug Name | Pyridoxal phosphate |
Target ID | BE0000778 |
UniProt ID | O95470 |
Regulation Type | cofactor |
PubMed IDs | 15522238; 11377878 |
Citations | Ikeda M, Kihara A, Igarashi Y: Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun. 2004 Dec 3;325(1):338-43.@@Bobbin RP: PPADS, an ATP antagonist, attenuates the effects of a moderately intense sound on cochlear mechanics. Hear Res. 2001 Jun;156(1-2):10-6. |
Groups | Approved; Investigational; Nutraceutical |
Direct Classification | Pyridoxals and derivatives |
SMILES | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O |
Pathways | Histidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling |
PharmGKB | PA164749650 |
ChEMBL | CHEMBL82202 |